Tags: dart therapeutics, executive team
add a comment
On September 10th MBBP client DART Therapeutics LLC announced it has named its new Executive Team including co-founder and executive chairman, Gene W. Williams as its CEO. Founded in 2010 by Williams and patient foundations the Nash Avery Foundation and Charley’s Fund, DART is a patient-funded biotech business focused on Duchenne Muscular Dystrophy (DMD) and other rare diseases. In addition to Williams, DART also appointed Ernest Bush as chief scientific officer; Dr. Elliot Goldstein as its chief medical officer; and Cabot Brown as chief financial officer.
For more information, please see the full press release.